01 / Contract Profile
W81XWH20C0030 Federal Contract Award
Agency code 97DH
PHASE III CLINICAL TRIALS
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
W81XWH20C0030 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$17.12M
FY 2026Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2023 | $5.94M | 2 | — |
| FY 2024 | $31.12M | 4 | +423.7% |
| FY 2025 | $0 | 2 | −100.0% |
| FY 2026 | $17.12M | 2 | — |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) | ARMY MED RES ACQ ACTIVITY |
05 / Contractor
Who holds this federal contract?
CELLPHIRE, INC
UEI F42VPQJ8LJL4 · CAGE 48GV8
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $54.18M | 10 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN94 | R&D- MEDICAL: OTHER (ENGINEERING DEVELOPMENT) | $54.18M | 10 | 100.0% |
08 / Place of Performance
Where is the work recorded?
ROCKVILLE, MONTGOMERY, MARYLAND, UNITED STATES
ZIP 208506325
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Apr 14, 2026 | P00020 | $10.36M | ARMY MED RES ACQ ACTIVITYOffice code HT9425 | 541715 | AN94 |
| Jan 28, 2026 | P00019 | $6.75M | ARMY MED RES ACQ ACTIVITYOffice code HT9425 | 541715 | AN94 |
| Nov 25, 2025 | P00018 | -$6.75M | ARMY MED RES ACQ ACTIVITYOffice code HT9425 | 541715 | AN94 |
| Mar 31, 2025 | P00017 | $6.75M | ARMY MED RES ACQ ACTIVITYOffice code HT9425 | 541715 | AN94 |
| Nov 27, 2024 | P00016 | $9.06M | ARMY MED RES ACQ ACTIVITYOffice code HT9425 | 541715 | AN94 |
| Nov 25, 2024 | P00015 | -$2.1K | ARMY MED RES ACQ ACTIVITYOffice code HT9425 | 541715 | AN94 |
| Jun 5, 2024 | P00014 | $0 | ARMY MED RES ACQ ACTIVITYOffice code HT9425 | 541715 | AN94 |
| Mar 8, 2024 | P00013 | $22.06M | ARMY MED RES ACQ ACTIVITYOffice code HT9425 | 541715 | AN94 |
| Oct 11, 2023 | P00012 | $1.12M | ARMY MED RES ACQ ACTIVITYOffice code HT9425 | 541715 | AN94 |
| Apr 26, 2023 | P00011 | $4.83M | ARMY MED RES ACQ ACTIVITYOffice code HT9425 | 541715 | AN94 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.